Given the intricate and unpredictable nature of pharmaceutical development, agility, flexibility and a customer focus have become indispensable for drug developers seeking CDMO partners. In this article, we look at the distinctive value proposition of 53Biologics’ services and how these solutions are tailored to the specific requirements of its clients.
“Our clients are the innovators who develop treatments that are currently not available. We are committed to supporting those innovators by taking their molecule through the development journey successfully from the beginning. We care about and consider the business achievement they want when working with us.”
— Pablo Gutiérrez, CEO of 53Biologics
Agile Solutions
53Biologics can react promptly and in a planned, risk-based manner, delivering new medicines within the most efficient timelines, regardless of the challenges encountered during development. This flexibility allows the company to adapt its strategy based on what is optimal for the molecule, overcoming unforeseen obstacles and maximizing the probability of success.
Our team is dedicated to helping pharmaceutical and biotechnology companies achieve their development milestones, ensuring that programs run smoothly and timelines are met. By combining scientific and regulatory expertise with dedicated teamwork and meticulous planning, we continuously adapt to innovation and use advanced technology to assess risks and manage challenges without compromising on quality.
Flexible Solutions
For every project, our experts and scientists from each field come together to understand the unique characteristics of the client’s protein of interest. Based on our development experience and an in-depth analysis, we draw up a personalized solution tailored to the client’s needs. During development, close communication and collaboration across teams allow us to respond promptly whenever an issue arises.
53Biologics provides a smooth transition from development to clinical manufacturing and beyond. The company offers bioreactors at multiple scales, ranging from 1 L to 2,000 L, along with GMP capabilities, robust technology transfer and raw material procurement. With experience in facility operations and regulatory inspections, 53Biologics supports its clients from development through to commercialization. Part of that support is helping clients clearly define drug substance vs drug product manufacturing roles from the start.
Customer-Focused Approach
“As a trusted CDMO partner, we do our best to address continuously changing client needs during the course of development without any road bumps, while providing full transparency to our clients along the way. Clients want us to step up in every aspect; they value our opinion in decision-making when carrying out the program.”
— Elena Hernández, Project Management Director at 53Biologics
In an increasingly competitive market, a robust development plan that identifies potential risks while prioritizing speed and quality from the initial stages is essential. 53Biologics continues to optimize processes, train personnel and expand its capacity, with client satisfaction as its top priority. This commitment to excellence has been recognized with the biotechnology innovation award at Farmaforum.
The company recognizes that each recombinant protein is unique, and its dedicated team provides meticulous support at every stage of the journey to realize its full potential. 53Biologics is committed to delivering on its promises to clients, ensuring the success of their programs and, ultimately, helping patients with unmet medical needs.
If you are a biotech company looking to outsource your project from cell line development to IND, 53Biologics offers the experience and innovative solutions tailored to your needs.
About 53Biologics
53Biologics is a CDMO specialized in biologics production. It is a leading biopharma company providing services from preclinical and clinical development to GMP manufacturing, supporting its clients in getting their biological products to market as quickly as possible.
For more information, contact Patricia De La Madrid, Marketing & Business Development Manager at 53Biologics, at pdelamadrid@53biologics.com.